Polytopic protein topology is established in the endoplasmic reticulum (ER) by sequence determinants encoded throughout the nascent polypeptide. Here we characterize 12 topogenic determinants in the cystic fibrosis transmembrane conductance regulator, and identify a novel mechanism by which a charged residue is positioned within the plane of the lipid bilayer. During cystic fibrosis transmembrane conductance regulator biogenesis, topology of the C-terminal transmembrane domain (TMs 7-12) is directed by alternating signal (TMs 7, 9, and 11) and stop transfer (TMs 8, 10, and 12) sequences. Unlike conventional stop transfer sequences, however, TM8 is unable to independently terminate translocation due to the presence of a single charged residue, Asp 924 , within the TM segment. Instead, TM8 stop transfer activity is specifically dependent on TM7, which functions both to initiate translocation and to compensate for the charged residue within TM8. Moreover, even in the presence of TM7, the N terminus of TM8 extends significantly into the ER lumen, suggesting a high degree of flexibility in establishing TM8 transmembrane boundaries. These studies demonstrate that signal sequences can markedly influence stop transfer behavior and indicate that ER translocation machinery simultaneously integrates information from multiple topogenic determinants as they are presented in rapid succession during polytopic protein biogenesis.The topology of most eukaryotic polytopic proteins is generated in the endoplasmic reticulum (ER) 1 through the collective action of sequence determinants encoded within the nascent polypeptide. These determinants encompass hydrophobic transmembrane (TM) segments that, together with their flanking residues, interact with cytosolic and ER translocation machinery to initiate and terminate translocation and integrate the polypeptide into the lipid bilayer (reviewed in Refs. 1-3). In the simplest model, topology can be established cotranslationally by alternating topogenic determinants that function as signal (anchor) and stop transfer sequences (4 -7). As the first signal sequence emerges from the ribosome, it targets the ribosome nascent-chain complex (RNC) to the ER and gates open an aqueous channel in the membrane (the Sec61 translocon) (8). Because the ribosome exit site is directly aligned with the axial pore of the translocon, newly synthesized polypeptide is cotranslationally directed into the aqueous environment of the translocon as it emerges from the ribosome (9 -11). Subsequent synthesis of a stop transfer sequence gates the translocon closed to the ER lumen, terminates translocation, and provides the growing nascent polypeptide access to the cytosol (12, 13). Through sequential iterations of these events, signal and stop transfer sequences can alternately direct the polypeptide into the ER lumen or the cytosol and thus establish topology of transmembrane segments and lumenal and cytosolic peptide loops.Not all native polytopic proteins utilize a simple cotranslational biogenesis pathway. For ex...
In the past decade major advances have been made towards understanding the mechanisms by which polytopic membrane proteins fold and assemble in cellular membranes. In eukaryotes, this process is mediated by a complex set of machinery in the endoplasmic reticulum (ER) that facilitates translocation of peptide loops across and integration of hydrophobic helices into the lipid bilayer. Studies evaluating the biogenesis of P-glycoprotein (P-gp) have been at the forefront of this rapidly expanding field. They have revealed a fascinating although sometimes confusing picture that has challenged our notions about general mechanisms of polytopic protein assembly and questioned specific predictions about the details and uniqueness of P-gp transmembrane topology. This review will attempt to summarize and consolidate our current knowledge of the sequence of events that gives rise to P-gp topology in the ER compartment and the implications of these events for polytopic protein biogenesis and function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.